Glutathione S-Transferase M1 Polymorphism and Sporadic Colorectal Cancer Risk: An Updating Meta-Analysis and HuGE Review of 36 Case-Control Studies

Annals of Epidemiology

Volumn 20, Issue 2, 2010, Pages 108-121

  Gao, Yong ^a   Cao, Yunfei ^a   Tan, Aihua ^a   Liao, Cun ^a   Mo, Zengnan ^a   Gao, Feng ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal Cancer; Epidemiology; Glutathione S Transferase; Meta Analysis

Indexed keywords

GLUTATHIONE TRANSFERASE M1;

ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; COLORECTAL CANCER; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; POLYMORPHISM, GENETIC;

EID: 73549089500     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2009.10.003     Document Type: Article

References (84)

1. Hayes J.D., and Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30 (1995) 445-600
2. Ketterer B.A. bird's eye view of the glutathione transferase field. Chem Biol Interact 138 (2001) 27-42
3. Mannervik B., and Danielson U.H. Glutathione transferases-structure and catalytic activity. CRC Crit Rev Biochem 23 (1988) 283-337
4. Pickett C.B., and Lu A.Y. Glutathione S-transferases: gene structure, regulation, and biological function. Annu Rev Biochem 58 (1989) 743-764
5. Sheehan D., Meade G., Foley V.M., and Dowd C.A. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 360 (2001) 1-16
6. Eaton D.L., and Bammler T.K. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 49 (1999) 156-164
7. Armstrong R.N. Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol 10 (1997) 2-18
8. Vineis P., Malats N., Lang M., d'Errico A., Caporaso N., Cuzick J., and Boffetta P. Metabolic polymorphisms and susceptibility to cancer (1999), International Agency for Research on Cancer, Lyon
9. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 463 (2000) 247-283
10. Hecht S. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91 (1999) 1194-1210
11. Rebbeck T.R. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6 (1997) 733-743
12. Strange R.C., Matharoo B., Faulder G.C., Jones P., Cotton W., Elder J.B., et al. The human glutathione S-transferases: a case-control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis 12 (1991) 25-28
13. Zhong S., Wyllie A.H., Barnes D., Wolf C.R., and Spurr N.K. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14 (1993) 1821-1824
14. Zhong S., Howie A., Ketterer B., Taylor J., Hayes J.D., Beckett G.J., et al. Glutathione S-transferases mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 12 (1991) 1533-1537
15. Hengstler J., Arand M., Herrero M.E., and Oesch F. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res 154 (1998) 47-85
16. Cotton S.C., Sharp L., Little J., and Brockton N. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 151 (2000) 7-32
17. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics. CA Cancer J Clin 2005 55 (2002) 74-108
18. Ferlay J., Bray F., Pisani P., and Parkin D.M. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No 5, version 2.0 (2004), IARC Press, Lyon
19. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2005 Incidence and Mortality Web-based Report (2009), Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute, Atlanta
20. Bray F., and Atkin W. International cancer patterns in men: geographical and temporal variations in cancer risk and the role of gender. The Journal of Men's Health & Gender 1 (2004) 38-46
21. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., and Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 (2007) 581-592
22. Potter J.D. Reconciling the epidemiology, physiology, and molecular biology of colon cancer. JAMA 268 (1992) 1573-1577
23. Potter J.D., Slattery M.L., Bostick R.M., and Gapstur S.M. Colon cancer: a review of the epidemiology. Epidemiol Rev 15 (1993) 499-545
24. Kiyohara C. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer. J Epidemiol 10 (2000) 349-360
25. Solomon E. Colorectal cancer genes. Nature 343 (1990) 412-414
26. Muller H.H., Heinimann K., and Dobbie Z. Genetics of hereditary colon cancer - a basis for prevention?. Eur J Cancer 36 (2000) 1215-1223
27. Ye Z., and Parry J.M. A meta-analysis of 20 case-control studies of the glutathione S-transferase M1 (GSTM1) status and colorectal cancer risk. Med Sci Monit 9 (2003) SR83-91
28. Chen K., Jiang Q.T., and He H.Q. Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol 11 (2005) 331-335
29. Higgins J.P., Thompson S.G., Deeks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
30. Zintzaras E., Chatzoulis D.Z., Karabatsas C.H., and Stefanidis I. The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet 50 (2005) 267-275
31. Begg C.B., and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994) 1088-1101
32. Egger M., Smith G.D., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
33. Schlesselman J.J. Case-control studies, design, conduct, analysis (1982), Oxford University Press, Oxford
34. Stoehlmacher J., Park D.J., Zhang W., Yang D., Groshen S., Zahedy S., et al. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer 91 (2004) 344-354
35. Holley S.L., Rajagopal R., Hoban P.R., Deakin M., Fawole A.S., Elder J.B., et al. Polymorphisms in the glutathione S-transferase mu cluster are associated with tumour progression and patient outcome in colorectal cancer. Int J Oncol 28 (2006) 231-236
36. Lamberti C., Jungck M., Laarmann M., Knapp M., Caspari R., Friedl W., et al. Arylamine N-acetyltransferase type 2 and glutathione S-transferases M1 and T1 polymorphisms in familial adenomatous polyposis. Pharmacogenetics 12 (2002) 49-54
37. Berkhout M., Roelofs H.M., te Morsche R.H., Dekker E., van Krieken J.H., Nagengast F.M., et al. Detoxification enzyme polymorphisms are not involved in duodenal adenomatosis in familial adenomatous polyposis. Br J Surg 95 (2008) 499-505
38. Shin J.H., Ku J.L., Shin K.H., Shin Y.K., Kanq S.B., and Park J.G. Glutathione S-transferase M1 associated with cancer occurrence in Korean HNPCC families carrying the hMLH1/hMSH2 mutation. Oncol Rep 10 (2003) 483-486
39. Talseth B.A., Meldrum C., Suchy J., Kurzawski G., Lubinski J., and Scott R.J. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients. Cancer Epidemiol Biomarkers Prev 15 (2006) 2307-2310
40. Fan C., Jin M., Chen K., Zhang Y., Zhang S., and Liu B. Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer. BMC Cancer 7 (2007) 115
41. Yoshioka M., Katoh T., Nakano M., Takasawa S., Nagata N., and Itoh H. Glutathione S-transferase (GST) M1, T1, P1, N-acetyltransferase (NAT) 1 and 2 genetic polymorphisms and susceptibility to colorectal cancer. J UOEH 21 (1999) 133-147
42. Kampman E., Slattery M.L., Bigler J., Leppert M., Samowitz W., Caan B.J., et al. Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter case-control study. Cancer Epidemiol Biomarkers Prev 8 (1999) 15-24
43. Kiss I., Sandor J., Pajkos G., Bogner B., Hegedus G., and Ember I. Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes. Anticancer Res 20 (2000) 519-522
44. Slattery M.L., Potter J.D., Ma K.N., Caan B.J., Leppert M., and Samowitz W. Western diet, family history of colorectal cancer, NAT2, GSTM-1 and risk of colon cancer. Cancer Causes Control 11 (2000) 1-8
45. Slattery M.L., Kampman E., Samowitz W., Caan B.J., and Potter J.D. Interplay between dietary inducers of GST and the GSTM-1 genotype in colon cancer. Int J Cancer 87 (2000) 728-733
46. Seow A., Yuan J.M., Sun C.L., Van Den Berg D., Lee H.P., and Yu MC. Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study. Carcinogenesis 23 (2002) 2055-2061
47. Yeh C.C., Hsieh L.L., Tang R., Chang-Chieh C.R., and Sung F.C. Vegetable/fruit, smoking, glutathione S-transferase polymorphisms and risk for colorectal cancer in Taiwan. World J Gastroenterol 11 (2005) 1473-1480
48. Chenevix-Trench G., Young J., Coggan M., and Board P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 16 (1995) 1655-1657
49. Katoh T., Nagata N., Kuroda Y., Itoh H., Kawahara A., Kuroki N., et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 17 (1996) 1855-1859
50. Deakin M., Elder J., Hendrickse C., Peckham D., Wild N., Leopard P., et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 17 (1996) 881-884
51. Guo J.Y., Wan D.S., Zeng R.P., and Zhang Q. The polymorphism of GSTM1, mutagen sensitivity in colon cancer and healthy control. Mutat Res 372 (1996) 17-22
52. Gertig D.M., Stampfer M., Haiman C., Hennekens C.H., Kelsey K., and Hunter D.J. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev 7 (1998) 1001-1005
53. Lee E., Huang Y., Zhao B., Seow-Choen F., Balakrishnan A., and Chan S.H. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2. J Toxicol Sci 23 (1998) 140-142
54. Slattery M.L., Potter J.D., Samowitz W., Bigler J., Caan B., and Leppert M. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 7 (1998) 1079-1084
55. Abdel-Rahman S.Z., Soliman A.S., Bondy M.L., Wu X., El-Badawy S.A., Mahgoub K.G., et al. Polymorphism of glutathione S-transferase loci GSTM1 and GSTT1 and susceptibility to colorectal cancer in Egypt. Cancer Lett 142 (1999) 97-104
56. Welfare M., Monesola Adeokun A., Bassendine M.F., and Daly A.K. Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev 8 (1999) 289-292
57. Zhang H., Ahmadi A., Arbman G., Zdolsek J., Carstensen J., Nordenskjold B., et al. Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma. Int J Cancer 84 (1999) 135-138
58. Gawronska-Szklarz B., Lubinski J., Kladny J., Kurzawski G., Bielicki D., Wojcicki M., et al. Polymorphism of GSTM1 gene in patients with colorectal cancer and colonic polyps. Exp Toxicol Pathol 51 (1999) 321-325
59. Butler W.J., Ryan P., and Roberts-Thomson I.C. Metabolic genotypes and risk for colorectal cancer. J Gastroenterol Hepatol 16 (2001) 631-635
60. Loktionov A., Watson M.A., Gunter M., Stebbings W.S., Speakman C.T., Bingham S.A., et al. Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor. Carcinogenesis 22 (2001) 1053-1060
61. Saadat I., and Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett 169 (2001) 21-26
62. Tiemersma E.W., Kampman E., Bueno de Mesquita H.B., Bunschoten A., van Schothorst E.M., Kok F.J., et al. Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study. Cancer Causes Control 13 (2002) 383-393
63. Ye Z., and Parry J.M. Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer. Teratog Carcinog Mutagen 22 (2002) 385-392
64. Sachse C., Smith G., Wilkie M.J., Barrett J.H., Waxman R., Sullivan F., et al. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 23 (2002) 1839-1849
65. Zhu Y., Deng C., Zhang Y., Zhou X., and He X. The relationship between GSTM1, GSTT1 gene polymorphisms and susceptibility to sporadic colorectal adenocarcinoma. Zhonghua Nei Ke Za Zhi 41 (2002) 538-540
66. Laso N., Lafuente M.J., Mas S., Trias M., Ascaso C., Molina R., et al. Glutathione S-transferase (GSTM1 and GSTT1)-dependent risk for colorectal cancer. Anticancer Res 22 (2002) 3399-3403
67. Sgambato A., Campisi B., Zupa A., Bochicchio A., Romano G., Tartarone A., et al. Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy. Anticancer Res 22 (2002) 3647-3652
68. Nascimento H., Coy C.S., Teori M.T., Boin I.F., Goes J.R., Costa F.F., et al. Possible influence of glutathione S-transferase GSTT1 null genotype on age of onset of sporadic colorectal adenocarcinoma. Dis Colon Rectum 46 (2003) 510-515
69. Slattery M.L., Edwards S., Curtin K., Schaffer D., and Neuhausen S. Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer. Cancer Epidemiol Biomarkers Prev 12 (2003) 882-889
70. van der Hel O.L., Bueno de Mesquita H.B., Roest M., Schaffer D., and Neuhausen S. No modifying effect of NAT1, GSTM1, and GSTT1 on the relation between smoking and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 12 (2003) 681-682
71. Kiss I., Nemeth A., Bogner B., Pajkos G., Orsos Z., Sandor J., et al. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer. Anticancer Res 24 (2004) 3965-3970
72. van der Logt E.M., Bergevoet S.M., Roelofs H.M., van Hooijdonk Z., te Morsche R.H., Wobbes T., et al. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis 25 (2004) 2407-2415
73. Chen K., Jiang Q.T., Ma X.Y., Yao K.Y., Leng S.G., Yu W.P., et al. Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case-control study. Zhonghua Zhong Liu Za Zhi 26 (2004) 645-648
74. Ates N.A., Tamer L., Ates C., Ercan B., Elipek T., Ocal K., et al. Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer. Biochem Genet 43 (2005) 149-163
75. Huang K., Sandler R.S., Millikan R.C., Schroeder J.C., North K.E., and Hu J. GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a non-hospital case-control study in North Carolina (United States). Cancer Causes Control 17 (2006) 385-394
76. Little J., Sharp L., Masson L.F., Brockton N.T., Cotton S.C., Haites N.E., et al. Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in the Grampian region of Scotland. Int J Cancer 119 (2006) 2155-2164
77. Martinez C., Martin F., Fernandez J.M., Garcia-Martin E., Sastre J., Diaz-Rubio M., et al. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics 7 (2006) 711-718
78. Probst-Hensch N.M., Sun C.L., Van Den Berg D., Ceschi M., Koh W.P., and Yu M.C. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study. Carcinogenesis 27 (2006) 2475-2482
79. Skjelbred C.F., Saebo M., Hjartaker A., Grotmol T., Hansteen I.L., Tveit K.M., et al. Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas. BMC Cancer 7 (2007) 228
80. Yeh C.C., Sung F.C., Tang R., Chang-Chieh C.R., and Hsieh L.L. Association between polymorphisms of biotransformation and DNA-repair genes and risk of colorectal cancer in Taiwan. J Biomed Sci 14 (2007) 183-193
81. Yoshida K., Osawa K., Kasahara M., Miyaishi A., Nakanishi K., Hayamizu S., et al. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking. Asian Pac J Cancer Prev 8 (2007) 438-444
82. Csejtei A., Tibold A., Varga Z., Koltai K., Ember A., Orsos Z., et al. GSTM, GSTT and p53 polymorphisms as modifiers of clinical outcome in colorectal cancer. Anticancer Res 28 (2008) 1917-1922
83. Blettner M., Sauerbrei W., Schlehofer B., Scheuchenpflug T., and Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 28 (1999) 1-9
84. Martinez-Lara E., Siles E., Hernandez R., Cañuelo A.R., Luisa del Moral M., Jiménez A., et al. Glutathione S-transferase isoenzymatic response to aging in rat cerebral cortex and cerebellum. Neurobiol Aging 24 (2003) 501-509